Publicación: Development of Antibacterial and Antifungal Triazole Chromium(III) and Cobalt(II) Complexes : Synthesis and Biological Activity Evaluations
Development of Antibacterial and Antifungal Triazole Chromium(III) and Cobalt(II) Complexes : Synthesis and Biological Activity Evaluations
dc.contributor.author | Leal-Pinto, Sandra Milena | spa |
dc.contributor.author | Roa Cordero, Martha Viviana | spa |
dc.contributor.author | Nagles, Edgar | spa |
dc.contributor.author | Muñoz Castro, Alvaro | spa |
dc.contributor.author | Hurtado, John J. | spa |
dc.contributor.author | Murcia, Ricardo A. | spa |
dc.date.accessioned | 2019-06-20T13:15:22Z | spa |
dc.date.available | 2019-06-20T13:15:22Z | spa |
dc.date.issued | 2018-08-13 | spa |
dc.description | 16 p. | spa |
dc.description.abstract | In this work, six complexes (2–7) of Cr(III) and Co(II) transition metals with triazole ligands were synthesized and characterized. In addition, a new ligand, 3,5-bis(1,2,4-triazol-1-ylmethyl)toluene (1), was synthesized and full characterized. The complexes were obtained as air-stable solids and characterized by melting point, electrical conductivity, thermogravimetric analysis, and Raman, infrared and ultraviolet/visible spectroscopy. The analyses and spectral data showed that complexes 3–7 had 1:1 (M:L) stoichiometries and octahedral geometries, while 2 had a 1:2 (M:L) ratio, which was supported by DFT calculations. The complexes and their respective ligands were evaluated against bacterial and fungal strains with clinical relevance. All the complexes showed higher antibacterial and antifungal activities than the free ligands. The complexes were more active against fungi than against bacteria. The activities of the chromium complexes against Candida tropicalis are of great interest, as they showed minimum inhibitory concentration 50 (MIC50) values between 7.8 and 15.6 μg mL−1. Complexes 5 and 6 showed little effect on Vero cells, indicating that they are not cytotoxic. These results can provide an important platform for the design of new compounds with antibacterial and antifungal activities. | eng |
dc.format.mimetype | application/pdf | spa |
dc.identifier.doi | 10.3390/molecules23082013 | spa |
dc.identifier.issn | 1420-3049 | spa |
dc.identifier.uri | https://repositorio.udes.edu.co/handle/001/3167 | spa |
dc.language.iso | eng | spa |
dc.relation.ispartof | Molecules | spa |
dc.rights | Derechos Reservados - Universidad de Santander, 2018 | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.rights.creativecommons | Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | spa |
dc.source | https://www.mdpi.com/1420-3049/23/8/2013 | spa |
dc.subject.proposal | Triazole ligands | spa |
dc.subject.proposal | Cobalt(II) and chromium(III) complexes | spa |
dc.subject.proposal | Antibacterial activity | spa |
dc.subject.proposal | Antifungal activity | spa |
dc.title | Development of Antibacterial and Antifungal Triazole Chromium(III) and Cobalt(II) Complexes : Synthesis and Biological Activity Evaluations | spa |
dc.type | Artículo de revista | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | spa |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
dspace.entity.type | Publication | |
oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
Archivos
Paquete original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Development of antibacterial and antifungal triazole chromium(III) and cobalt(II) complexes. Synthesis and biological activity evaluations.pdf
- Tamaño:
- 2.31 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Documento Principal
Paquete de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 59 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: